LifeStance reports Q1 EPS 4c, consensus 6c

Reports Q1 revenue $403.5M, consensus $386.12M. “We delivered an exceptional quarter to begin the year, highlighted by strong revenue growth of 21%, net income growth of $13.5M, and Adjusted EBITDA growth of 48%,” said Dave Bourdon, CEO. “Our performance demonstrates that our differentiated model is meeting the societal trend of growing demand for mental healthcare. We also took an important step forward in our commitment to clinical excellence by announcing an outcomes study on approximately 180,000 LifeStance (LFST) patients that showed roughly three quarters reported clinically significant improvement in anxiety and depression.”